Fresenius SE & Co KGaA (FRE) NPV

Sell:€40.23Buy:€40.38Price decreased€0.24 (0.59%)

Prices delayed by at least 15 minutes
Sell:€40.23
Buy:€40.38
Change:Price decreased€0.24 (0.59%)
Prices delayed by at least 15 minutes
Sell:€40.23
Buy:€40.38
Change:Price decreased€0.24 (0.59%)
Prices delayed by at least 15 minutes

Company Information

About this company

Fresenius SE & Co KGaA is a Germany-based healthcare company. The Company has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.

Key people

Wolfgang Kirsch
Independent Chairman of the Supervisory Board
Ralf Kiesslich
Independent Member of the Supervisory Board, Employee Representative
Iris Loew-Friedrich
Independent Member of the Supervisory Board
Susanne Zeidler
Independent Member of the Supervisory Board
Christoph Zindel
Independent Member of the Supervisory Board
Michael Sen
Chairman of the Management Board, Chief Executive Officer
Gerd Krick
Chairman of the Management Board
Michael Diekmann
Independent Deputy Chairman of the Supervisory Board
Grit Genster
Deputy Chairman of the Supervisory Board, Employee Representatives
Sara Hennicken
Chief Financial Officer, Member of the Management Board
Pierluigi Antonelli
Member of the Management Board, Chief Executive Officer - Fresenius Kabi
Robert Moeller
Member of the Management Board, Chief Executive Officer of Fresenius Helios
Michael Moser
Member of the Management Board, Legal, Compliance, Risk Management, Sustainability, Human Resources Corporate Audit and Vamed
Click to see more

Key facts

  • Shares in issue
    563.24m
  • EPIC
    FRE
  • ISIN
    DE0005785604
  • Location
    Germany
  • Sector
    Healthcare
  • Industry
    Healthcare Facilities
  • Market cap
    €22.93bn
  • Employees
    178,394
  • Exchange
    XETRA
  • Index
    DAX Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.